The strong association of PSP and other tauopathies with common variation in the 17q21.31 locus in the absence of a MAPT coding region mutation favors genetic regulatory mechanisms as a causal driver [15–17, 37, 51–60]. Here, MAPT is linked to supranuclear palsy, progressive, 1.